Stability indicating methods for the determination of aceclofenac
Autor: | Nagiba Y Hasan, Badr E Elzeany, M Abdel-Elkawy, Nour E Wagieh |
---|---|
Rok vydání: | 2003 |
Předmět: |
Diclofenac
Chromatography medicine.diagnostic_test Chemistry Analytical chemistry Pharmaceutical Science Pharmaceutical formulation Third derivative chemistry.chemical_compound Drug Stability Phase (matter) Spectrophotometry Drug Discovery medicine Technology Pharmaceutical Aceclofenac Methanol Densitometry Quantitative analysis (chemistry) Chromatography High Pressure Liquid medicine.drug |
Zdroj: | Il Farmaco. 58:91-99 |
ISSN: | 0014-827X |
DOI: | 10.1016/s0014-827x(02)01271-5 |
Popis: | Five new selective, precise and accurate methods for the determination of aceclofenac in the presence of its degradation product; diclofenac are described. Method A utilizes third derivative spectrophotometry at 242 nm. Method B is RSD(1) spectrophotometric method based on the simultaneous use of the first derivative of ratio spectra and measurement at 245 nm. Method C is a pH-induced difference (deltaA) spectrophotometry using UV measurement at 273 nm. Method D is a spectrodensitometric one, which depends on the quantitative densitometric evaluation of thin layer chromatogram of aceclofenac at 275 nm. Method E is RP-HPLC that depends on using methanol: water (60:40 v/v) as mobile phase at a flow rate of 1 ml/min and UV detection at 275 nm. Regression analysis of a beer's plot showed good correlation in the concentration ranges 5-40, 10-40, 15-50, 50-200, 1-50 microg/ml for methods A, B, C, D and E, respectively. These methods are suitable as stability indicating methods for the determination of aceclofenac in presence of its main degradation product, diclofenac. The proposed methods were applied for the analysis of the drug in its pharmaceutical formulation and the results obtained were compared with those obtained with the official B.P. method. |
Databáze: | OpenAIRE |
Externí odkaz: |